Pan-cancer analysis of NADPH oxidase 4 identifying its prognostic and immunotherapy predictive value and in vitro experimental verification in glioblastoma
NOX4 can serve as a prognostic and immunotherapy response biomarker for various cancers and targeting NOX4 may be a feasible anti-tumor therapy and may have synergistic anti-tumor effects combined with immunotherapy.
Authors
- Xun Wu (ORCID: https://orcid.org/0000-0002-0742-7459)
- Tianqi Du (ORCID: https://orcid.org/0000-0002-1894-9607)
- Qiuning Zhang (ORCID: https://orcid.org/0000-0001-9476-1537)
- Zhen Yang (ORCID: https://orcid.org/0000-0002-5011-1556)
- Junru Chen (ORCID: https://orcid.org/0000-0003-4553-6979)
- Yanliang Chen (ORCID: https://orcid.org/0000-0003-0475-3774)
- Qian Wang (ORCID: https://orcid.org/0000-0003-3270-3248)
- Zhiqiang Liu (ORCID: https://orcid.org/0000-0003-2982-8381)
- Hongtao Luo (ORCID: https://orcid.org/0000-0002-2191-4552)
- Quanlin Guan (ORCID: https://orcid.org/0000-0001-8800-7570)
- Mingyu Tan (ORCID: https://orcid.org/0009-0003-8505-0057)
- Shilong Sun
Institutions
- Institute of Modern Physics (CN)
- First Hospital of Lanzhou University (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- International Immunopharmacology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1016/j.intimp.2024.113815
- Citations
- 2
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.37